Cited by 4vaccines and immunoinformatics approachesMonoclonal and Polyclonal Antibodies ResearchProtein Structure and Dynamics

NAStructuralDB : structural database to facilitate computational studies of molecular modeling and recognition of proteins with special focus on antibody–antigen interactions

Open access
Chomicz, Dawid, Dudzic, Paweł, Wrobel, Sonia, Gawlowski, Tomasz, Demharter, Samuel, Spreafico, Roberto, Minoux, Hervé, Phillips, Andrew +1 more·2026·mAbs

Published version of a preprint

Abstract

Studying the interactions between antibodies and antigens is fundamental to the development of novel therapeutic biologics. Predictions of such interactions start with data collection. Though there exist reliable resources to identify antibody structures in the Protein Data Bank (PDB), such data still requires substantial processing to be usable in predictive tasks. Redundancy in sequences needs to be removed to avoid data leakages between train, test, and validation sets. Descriptors such as surface accessibility, secondary structure, and antibody region information need to be additionally annotated. Information on inter- and intra-molecular contacts, which is crucial to studying paratope/epitope information, needs to be collected. The specialized immunoglobulin format of Nanobodies® requires a separate dataset mirroring that of antibodies, given that their structure contains only a single VHH chain. Because antibody-antigen structures account for a small amount of all protein-protein contacts, having a molecular contact reference from other proteins is also desired. To address these issues, we introduce NAStructuralDB (https://naturalantibody.com/na-structural/), a dataset of processed structures of antibodies, Nanobodies®, proteins, and their complexes with molecular contact information and associated annotations. We use the opportunity of having collected the contact data to provide a reference of binding propensities of different residues across distinct contact types.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/19420862.2026.2630438

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Authors
Chomicz, D., Dudzic, P., Wrobel, S., Gawlowski, T., Demharter, S., Spreafico, R., Minoux, H., Phillips, A., & Krawczyk, K.
Affiliations
  • Natural Antibody
  • Wrocław University of Science and Technology (PL)
  • Genmab (United States) (US)
  • Sanofi (France) (FR)
Corresponding author
Krawczyk, Konrad
Venue
mAbs
Published
2026-03-08
Volume
18
Issue
1
Pages
2630438-2630438
ISSN
  • 1942-0862 (ISSN-L)
  • 1942-0870
OpenAlex
W7134287346
Cited by
4
References
11
Citations by year
2026: 4
FWCI
8.27
Type
journal article
Language
en
Open access
Locations
  • mAbs (publishedVersion, cc-by-nc)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by-nc)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Development of the Specitope technology for bioinformatics-based prediction of B-cell-specific epitopes, enabling the ‘in silico’ identification of candidates for therapeutic antibodies (FEMP.01.01-IP.01-0319/23-00)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Monoclonal and Polyclonal Antibodies Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
Keywords
antigen-antibody reaction, nanobodies, VHH, protein-protein contacts, epitope prediction, antibody binding sites, surface accessibility, biologic therapeutics, protein-protein interaction prediction
MeSH terms
Antigen-Antibody Reactions, Epitopes, Antigens, Humans, Models, Molecular, Protein Conformation, Computational Biology, Databases, Protein, Single-Domain Antibodies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review